Derek A. Wainwright
Affiliations: | Northwestern University, Evanston, IL |
Area:
Cell Biology, Cell Imaging & Electrophysiology, Molecular Neuroscience, Neurobiology of Disease, NeuroimmunologyGoogle:
"Derek Wainwright"Mean distance: 106866
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Chen P, Khan F, Lin Y, et al. (2023) LDHA-regulated tumor-macrophage symbiosis promotes glioblastoma progression. Research Square |
| Nguyen TT, Shin DH, Sohoni S, et al. (2022) Reshaping the tumor microenvironment with oncolytic viruses, positive regulation of the immune synapse, and blockade of the immunosuppressive oncometabolic circuitry. Journal For Immunotherapy of Cancer. 10 |
| Xuan W, Hsu WH, Khan F, et al. (2022) Circadian Regulator CLOCK Drives Immunosuppression in Glioblastoma. Cancer Immunology Research |
| Najem H, Marisetty A, Horbinski C, et al. (2021) CD11c+CD163+ Cells and Signal Transducer and Activator of Transcription 3 (STAT3) Expression Are Common in Melanoma Leptomeningeal Disease. Frontiers in Immunology. 12: 745893 |
| Zhai L, Bell A, Ladomersky E, et al. (2021) Tumor cell IDO enhances immune suppression and decreases survival independent of tryptophan metabolism in glioblastoma. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research |
| Chuntova P, Chow F, Watchmaker P, et al. (2020) Unique challenges for glioblastoma immunotherapy - Discussions across neuro-oncology and non-neuro-oncology experts in cancer immunology. Neuro-Oncology |
| Roh M, Wainwright DA, Wu JD, et al. (2020) Targeting CD73 to augment cancer immunotherapy. Current Opinion in Pharmacology. 53: 66-76 |
| Zhai L, Bell A, Ladomersky E, et al. (2020) Immunosuppressive IDO in Cancer: Mechanisms of Action, Animal Models, and Targeting Strategies. Frontiers in Immunology. 11: 1185 |
| Ladomersky E, Zhai L, Lauing KL, et al. (2020) Advanced Age Increases Immunosuppression in the Brain and Decreases Immunotherapeutic Efficacy in Subjects with Glioblastoma. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research |
| Basher F, Dhar P, Wang X, et al. (2020) Antibody targeting tumor-derived soluble NKG2D ligand sMIC reprograms NK cell homeostatic survival and function and enhances melanoma response to PDL1 blockade therapy. Journal of Hematology & Oncology. 13: 74 |